US Stock MarketDetailed Quotes

CTKB Cytek Biosciences

Watchlist
  • 5.610
  • -0.060-1.06%
Close Aug 27 16:00 ET
  • 5.610
  • 0.0000.00%
Post 20:01 ET
737.75MMarket Cap-40071P/E (TTM)

Cytek Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
317.68%6.2M
38.45%3.96M
143.18%5.28M
53.59%9.51M
43.51%-4.24M
69.81%-2.85M
293.11%2.86M
-364.17%-12.23M
13.67%6.19M
-746.34%-7.5M
Net income from continuing operations
-137.78%-10.43M
9.37%-6.17M
-589.05%-12.15M
48.01%5.5M
-497.05%-6.46M
-525.07%-4.39M
-215.43%-6.81M
-17.94%2.48M
419.14%3.72M
14.51%1.63M
Operating gains losses
44.54%-1.18M
26.90%-1.16M
-8,541.56%-6.65M
---1.4M
---1.55M
---2.12M
---1.58M
-92.50%-77K
----
----
Depreciation and amortization
1.43%2.48M
36.59%2.46M
63.10%9.23M
30.10%2.43M
231.91%2.56M
57.34%2.45M
22.52%1.8M
355.64%5.66M
172.12%1.86M
307.94%771K
Other non cash items
-49.13%146K
-44.67%301K
-27.59%1.58M
-53.09%266K
-14.89%480K
-47.72%287K
9.24%544K
10.39%2.18M
-25.20%567K
28.47%564K
Change In working capital
259.15%8.11M
-49.99%1.85M
73.68%-10.51M
19.01%-3.84M
64.87%-5.27M
66.01%-5.09M
171.01%3.69M
-361.81%-39.93M
-336.17%-4.74M
-339.60%-15M
-Change in receivables
187.03%5.92M
-30.06%4.24M
62.86%-7.33M
103.30%263K
-79.51%-6.85M
1.82%-6.8M
683.33%6.06M
-59.65%-19.74M
-1,006.11%-7.96M
31.77%-3.82M
-Change in inventory
46.12%4.43M
249.72%4.77M
124.28%4.29M
236.15%6.33M
63.57%-1.89M
135.91%3.03M
46.16%-3.19M
-149.76%-17.65M
184.48%1.88M
-437.55%-5.18M
-Change in prepaid assets
214.34%3.47M
-2,050.74%-2.93M
50.86%-9.52M
-65.91%-7.18M
113.07%833K
29.68%-3.03M
96.87%-136K
-209.69%-19.36M
-246.16%-4.33M
-160.57%-6.37M
-Change in payables and accrued expense
-52.03%-5.31M
-292.65%-3.98M
-111.31%-1.06M
-144.86%-1.68M
336.85%2.04M
-211.78%-3.49M
-38.03%2.07M
-12.96%9.33M
-54.11%3.73M
-138.72%-863K
-Change in other current liabilities
23.24%-436K
24.88%-794K
-78.50%-3.41M
9.88%-885K
-35.79%-903K
-24.56%-568K
-653.40%-1.06M
48.23%-1.91M
81.49%-982K
-202.78%-665K
-Change in other working capital
-99.31%40K
1,206.12%542K
-30.72%6.52M
-123.88%-696K
-21.23%1.5M
186.07%5.77M
-101.90%-49K
-6.00%9.41M
-13.63%2.92M
-30.07%1.9M
Cash from discontinued investing activities
Operating cash flow
317.68%6.2M
38.45%3.96M
143.18%5.28M
53.59%9.51M
43.51%-4.24M
69.81%-2.85M
293.11%2.86M
-364.17%-12.23M
13.67%6.19M
-746.34%-7.5M
Investing cash flow
Cash flow from continuing investing activities
-27.53%2.02M
96.59%-5.75M
-67.94%-93.89M
156.92%29.07M
3,849.91%43.12M
195.71%2.79M
-21,550.51%-168.87M
-166.32%-55.91M
-179.10%-51.06M
12.08%-1.15M
Net PPE purchase and sale
25.59%-977K
-12.28%-567K
52.32%-4.65M
77.03%-1.5M
-19.82%-1.33M
1.13%-1.31M
35.26%-505K
-123.37%-9.75M
-403.86%-6.53M
15.14%-1.11M
Net intangibles purchase and sale
-169.09%-148K
---55K
-49.17%-179K
23.75%-61K
-57.50%-63K
---55K
--0
---120K
---80K
---40K
Net business purchase and sale
--0
--0
---45.13M
---1K
---1K
--0
---45.13M
--0
--0
--0
Net investment purchase and sale
-24.31%3.15M
95.84%-5.13M
4.57%-43.94M
168.90%30.63M
--44.52M
362.00%4.16M
---123.24M
---46.04M
---44.45M
--0
Cash from discontinued investing activities
Investing cash flow
-27.53%2.02M
96.59%-5.75M
-67.94%-93.89M
156.92%29.07M
3,849.91%43.12M
195.71%2.79M
-21,550.51%-168.87M
-166.32%-55.91M
-179.10%-51.06M
12.08%-1.15M
Financing cash flow
Cash flow from continuing financing activities
-892.13%-1.71M
1.61M
-858.43%-41.81M
-976.73%-33.75M
-5,438.06%-8.27M
-81.12%216K
0
-97.42%5.51M
22,547.06%3.85M
-99.93%155K
Net issuance payments of debt
-0.71%-142K
959.59%1.26M
-119.26%-565K
-104.77%-140K
---138K
---141K
---146K
205.81%2.93M
--2.93M
--0
Net common stock issuance
----
----
---44.15M
---34.74M
---8.43M
----
----
--0
--0
--0
Proceeds from stock option exercised by employees
-15.04%1.23M
149.26%506K
19.15%3.32M
24.49%1.23M
95.13%441K
19.65%1.45M
-44.23%203K
334.42%2.79M
5,711.76%988K
-26.62%226K
Net other financing activities
-17.12%-130K
-159.65%-148K
-100.48%-419K
-43.66%-102K
-109.86%-149K
---111K
---57K
---209K
---71K
---71K
Cash from discontinued financing activities
Financing cash flow
-892.13%-1.71M
--1.61M
-858.43%-41.81M
-976.73%-33.75M
-5,438.06%-8.27M
-81.12%216K
--0
-97.42%5.51M
22,547.06%3.85M
-99.93%155K
Net cash flow
Beginning cash position
27.76%169.14M
-44.03%167.63M
-17.86%299.5M
-52.09%163.63M
-62.40%131.54M
-63.48%132.39M
-17.86%299.5M
119.49%364.62M
-9.36%341.52M
118.89%349.89M
Current changes in cash
4,076.28%6.52M
99.89%-184K
-108.26%-130.43M
111.76%4.82M
460.17%30.61M
101.39%156K
-8,656.12%-166.02M
-131.76%-62.63M
-219.70%-41.02M
-103.92%-8.5M
Effect of exchange rate changes
324.85%2.26M
255.50%1.7M
41.99%-1.45M
17.86%-823K
1,051.56%1.47M
28.19%-1.01M
-404.63%-1.09M
-291.17%-2.49M
-247.79%-1M
2,233.33%128K
End cash Position
35.25%177.92M
27.76%169.14M
-44.03%167.63M
-44.03%167.63M
-52.09%163.63M
-62.40%131.54M
-63.48%132.39M
-17.86%299.5M
-17.86%299.5M
-9.36%341.52M
Free cash flow
218.61%5M
41.73%3.34M
102.05%454K
2,006.71%7.95M
34.92%-5.63M
60.83%-4.22M
204.12%2.35M
-8,407.89%-22.1M
-110.04%-417K
-5,787.07%-8.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 317.68%6.2M38.45%3.96M143.18%5.28M53.59%9.51M43.51%-4.24M69.81%-2.85M293.11%2.86M-364.17%-12.23M13.67%6.19M-746.34%-7.5M
Net income from continuing operations -137.78%-10.43M9.37%-6.17M-589.05%-12.15M48.01%5.5M-497.05%-6.46M-525.07%-4.39M-215.43%-6.81M-17.94%2.48M419.14%3.72M14.51%1.63M
Operating gains losses 44.54%-1.18M26.90%-1.16M-8,541.56%-6.65M---1.4M---1.55M---2.12M---1.58M-92.50%-77K--------
Depreciation and amortization 1.43%2.48M36.59%2.46M63.10%9.23M30.10%2.43M231.91%2.56M57.34%2.45M22.52%1.8M355.64%5.66M172.12%1.86M307.94%771K
Other non cash items -49.13%146K-44.67%301K-27.59%1.58M-53.09%266K-14.89%480K-47.72%287K9.24%544K10.39%2.18M-25.20%567K28.47%564K
Change In working capital 259.15%8.11M-49.99%1.85M73.68%-10.51M19.01%-3.84M64.87%-5.27M66.01%-5.09M171.01%3.69M-361.81%-39.93M-336.17%-4.74M-339.60%-15M
-Change in receivables 187.03%5.92M-30.06%4.24M62.86%-7.33M103.30%263K-79.51%-6.85M1.82%-6.8M683.33%6.06M-59.65%-19.74M-1,006.11%-7.96M31.77%-3.82M
-Change in inventory 46.12%4.43M249.72%4.77M124.28%4.29M236.15%6.33M63.57%-1.89M135.91%3.03M46.16%-3.19M-149.76%-17.65M184.48%1.88M-437.55%-5.18M
-Change in prepaid assets 214.34%3.47M-2,050.74%-2.93M50.86%-9.52M-65.91%-7.18M113.07%833K29.68%-3.03M96.87%-136K-209.69%-19.36M-246.16%-4.33M-160.57%-6.37M
-Change in payables and accrued expense -52.03%-5.31M-292.65%-3.98M-111.31%-1.06M-144.86%-1.68M336.85%2.04M-211.78%-3.49M-38.03%2.07M-12.96%9.33M-54.11%3.73M-138.72%-863K
-Change in other current liabilities 23.24%-436K24.88%-794K-78.50%-3.41M9.88%-885K-35.79%-903K-24.56%-568K-653.40%-1.06M48.23%-1.91M81.49%-982K-202.78%-665K
-Change in other working capital -99.31%40K1,206.12%542K-30.72%6.52M-123.88%-696K-21.23%1.5M186.07%5.77M-101.90%-49K-6.00%9.41M-13.63%2.92M-30.07%1.9M
Cash from discontinued investing activities
Operating cash flow 317.68%6.2M38.45%3.96M143.18%5.28M53.59%9.51M43.51%-4.24M69.81%-2.85M293.11%2.86M-364.17%-12.23M13.67%6.19M-746.34%-7.5M
Investing cash flow
Cash flow from continuing investing activities -27.53%2.02M96.59%-5.75M-67.94%-93.89M156.92%29.07M3,849.91%43.12M195.71%2.79M-21,550.51%-168.87M-166.32%-55.91M-179.10%-51.06M12.08%-1.15M
Net PPE purchase and sale 25.59%-977K-12.28%-567K52.32%-4.65M77.03%-1.5M-19.82%-1.33M1.13%-1.31M35.26%-505K-123.37%-9.75M-403.86%-6.53M15.14%-1.11M
Net intangibles purchase and sale -169.09%-148K---55K-49.17%-179K23.75%-61K-57.50%-63K---55K--0---120K---80K---40K
Net business purchase and sale --0--0---45.13M---1K---1K--0---45.13M--0--0--0
Net investment purchase and sale -24.31%3.15M95.84%-5.13M4.57%-43.94M168.90%30.63M--44.52M362.00%4.16M---123.24M---46.04M---44.45M--0
Cash from discontinued investing activities
Investing cash flow -27.53%2.02M96.59%-5.75M-67.94%-93.89M156.92%29.07M3,849.91%43.12M195.71%2.79M-21,550.51%-168.87M-166.32%-55.91M-179.10%-51.06M12.08%-1.15M
Financing cash flow
Cash flow from continuing financing activities -892.13%-1.71M1.61M-858.43%-41.81M-976.73%-33.75M-5,438.06%-8.27M-81.12%216K0-97.42%5.51M22,547.06%3.85M-99.93%155K
Net issuance payments of debt -0.71%-142K959.59%1.26M-119.26%-565K-104.77%-140K---138K---141K---146K205.81%2.93M--2.93M--0
Net common stock issuance -----------44.15M---34.74M---8.43M----------0--0--0
Proceeds from stock option exercised by employees -15.04%1.23M149.26%506K19.15%3.32M24.49%1.23M95.13%441K19.65%1.45M-44.23%203K334.42%2.79M5,711.76%988K-26.62%226K
Net other financing activities -17.12%-130K-159.65%-148K-100.48%-419K-43.66%-102K-109.86%-149K---111K---57K---209K---71K---71K
Cash from discontinued financing activities
Financing cash flow -892.13%-1.71M--1.61M-858.43%-41.81M-976.73%-33.75M-5,438.06%-8.27M-81.12%216K--0-97.42%5.51M22,547.06%3.85M-99.93%155K
Net cash flow
Beginning cash position 27.76%169.14M-44.03%167.63M-17.86%299.5M-52.09%163.63M-62.40%131.54M-63.48%132.39M-17.86%299.5M119.49%364.62M-9.36%341.52M118.89%349.89M
Current changes in cash 4,076.28%6.52M99.89%-184K-108.26%-130.43M111.76%4.82M460.17%30.61M101.39%156K-8,656.12%-166.02M-131.76%-62.63M-219.70%-41.02M-103.92%-8.5M
Effect of exchange rate changes 324.85%2.26M255.50%1.7M41.99%-1.45M17.86%-823K1,051.56%1.47M28.19%-1.01M-404.63%-1.09M-291.17%-2.49M-247.79%-1M2,233.33%128K
End cash Position 35.25%177.92M27.76%169.14M-44.03%167.63M-44.03%167.63M-52.09%163.63M-62.40%131.54M-63.48%132.39M-17.86%299.5M-17.86%299.5M-9.36%341.52M
Free cash flow 218.61%5M41.73%3.34M102.05%454K2,006.71%7.95M34.92%-5.63M60.83%-4.22M204.12%2.35M-8,407.89%-22.1M-110.04%-417K-5,787.07%-8.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg